As prescription drug prices rise, politicians, journalists, physicians
and pharmaceutical companies play the blame game. It used to be
that drug companies received all the grief but their recent rebuttals
have put the magnifying glass on others, especially doctors.
In the face of FDA advisory committees and Attorney General lawsuits,
big name drug companies have volunteered to post results of all
clinical trials, even those unfavorable to their products.
Others have followed suit. The AMA is developing criteria for a
mandatory national registry of clinical trials, and more than 10
top medical journals announced they will only publish studies if
all the clinical trials have been made available on a public registry.
However, authors of four new books still say the drug industry
and doctors who profit from it care more about dollars than making
sense of health problems. According to these experts, pharmaceutical
firms invest in getting the support they want -- from taking a
doctor out to lunch to funding most medical studies.
Several experts from various fields showed concern over "me-too"
drugs, or prescription medications that are similar to others on
the market. Critics say companies do this to save money because
the process is easier than finding breakthrough medications, which
are sorely needed. Pharmaceutical company officials insist these
medications work better in some patients than the original drug
and they offer patients a cheaper alternative.
Experts say it is hard to find researchers who have no ties to
drug companies and that they should be the ones coming out about
negative studies.
Still, others say the only source for information is the drug companies
and the need for neutral sources is great. Some states have taken
this problem into their own hands and will send out pharmaceutical
experts to visit practices and promote cost-effective treatments.
USA
Today September 14, 2004
|